|
SLC35A3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.10750000281712E-08 |
| Normal-vs-Stage3 |
7.07099999996963E-07 |
| Normal-vs-Stage4 |
1.384120E-04 |
| Stage1-vs-Stage2 |
5.094600E-01 |
| Stage1-vs-Stage3 |
2.270400E-01 |
| Stage1-vs-Stage4 |
2.186600E-01 |
| Stage2-vs-Stage3 |
6.196600E-01 |
| Stage2-vs-Stage4 |
5.245200E-01 |
| Stage3-vs-Stage4 |
8.726400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
2.53699949936959E-10 |
| Normal-vs-Asian |
1.378780E-01 |
| Caucasian-vs-AfricanAmerican |
2.841200E-01 |
| Caucasian-vs-Asian |
4.971400E-01 |
| AfricanAmerican-vs-Asian |
4.899400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
8.77729999793075E-08 |
| Male-vs-Female |
5.998500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.32879970652311E-10 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
8.3544282603043E-13 |
| Normal-vs-Extreme_Obese |
1.8045699999969E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.078230E-01 |
| Normal_Weight-vs-Obese |
7.939000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.406600E-01 |
| Extreme_Weight-vs-Obese |
1.277510E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.529600E-01 |
| Obese-vs-Extreme_Obese |
9.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.613800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.47060000527711E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.786600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.178750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.747250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.979800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.146400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.278600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.67559996380839E-09 |
| Normal-VS-KIRP CIMP |
8.597000E-03 |
| Normal-VS-Unclassified PRCC |
1.96920002526468E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.998000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.675600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.615600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.295200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.085200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.455800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.5852210917019E-14 |
| Normal-vs-N1 |
1.209360E-04 |
| Normal-vs-N2 |
1.637680E-03 |
| N0-vs-N1 |
6.378000E-02 |
| N0-vs-N2 |
8.307000E-01 |
| N1-vs-N2 |
5.051800E-01 |
|
|
